Immix Biopharma, Inc. (IMMX)
7.48
-0.36
(-4.59%)
USD |
NASDAQ |
Nov 16, 16:00
7.49
+0.01
(+0.13%)
After-Hours: 20:00
Immix Biopharma Price to Book Value : 1.871 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.871 |
| November 13, 2026 | 1.961 |
| November 12, 2026 | 2.019 |
| November 11, 2026 | 2.166 |
| November 10, 2026 | 2.089 |
| November 09, 2026 | 2.144 |
| November 06, 2026 | 2.016 |
| November 05, 2026 | 1.801 |
| November 04, 2026 | 1.994 |
| November 03, 2026 | 1.929 |
| November 02, 2026 | 1.816 |
| October 30, 2026 | 1.921 |
| October 29, 2026 | 1.996 |
| October 28, 2026 | 2.032 |
| October 27, 2026 | 2.014 |
| October 26, 2026 | 2.016 |
| October 23, 2026 | 2.039 |
| October 22, 2026 | 2.089 |
| October 21, 2026 | 2.129 |
| October 20, 2026 | 2.229 |
| October 19, 2026 | 2.056 |
| October 16, 2026 | 1.996 |
| October 15, 2026 | 2.171 |
| October 14, 2026 | 2.129 |
| October 13, 2026 | 2.174 |
| Date | Value |
|---|---|
| October 12, 2026 | 2.314 |
| October 09, 2026 | 2.366 |
| October 08, 2026 | 2.324 |
| October 07, 2026 | 2.374 |
| October 06, 2026 | 2.411 |
| October 05, 2026 | 2.534 |
| October 02, 2026 | 2.421 |
| October 01, 2026 | 2.559 |
| September 30, 2026 | 2.603 |
| September 29, 2026 | 3.294 |
| September 28, 2026 | 3.584 |
| September 25, 2026 | 3.428 |
| September 24, 2026 | 3.656 |
| September 23, 2026 | 3.725 |
| September 22, 2026 | 4.009 |
| September 21, 2026 | 3.897 |
| September 18, 2026 | 3.906 |
| September 17, 2026 | 3.975 |
| September 16, 2026 | 3.725 |
| September 15, 2026 | 3.794 |
| September 14, 2026 | 3.816 |
| September 11, 2026 | 3.794 |
| September 10, 2026 | 3.969 |
| September 09, 2026 | 3.847 |
| September 08, 2026 | 4.141 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.325 |
| Alnylam Pharmaceuticals, Inc. | 5.934 |
| Anika Therapeutics, Inc. | 1.258 |
| Savara, Inc. | 8.509 |
| Arrowhead Pharmaceuticals, Inc. | 124.15 |
Price to Book Value Related Metrics
| PEG Ratio | -1.591 |
| Price | 7.48 |
| Earnings Yield | -11.10% |
| Market Cap | 626.92M |
| PEGY Ratio | -1.591 |